Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Small Cell Lung Extensive Stage”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05092412
What this trial is testing

Low-dose Radiotherapy Combined With Durvalumab, Chemotherapy(EP) in the Treatment of ES-SCLC

Who this might be right for
Lung CancerExtensive-stage Small-cell Lung CancerDurvalumab
You Lu 30
Testing effectiveness (Phase 2)Looking for participantsNCT06610734
What this trial is testing

Multicenter, Phase II Randomized Controlled Study of Adebrelimab Combined With Chemotherapy and Concurrent Low-Dose Radiotherapy (LDRT) for the Treatment of Extensive-Stage Small Cell Lung Cancer (SCLC)

Who this might be right for
Small Cell Lung Cancer Extensive Stage
Sichuan University 202
Testing effectiveness (Phase 2)UnknownNCT04683198
What this trial is testing

Camrelizumab Combined With Apatinib ,Carboplatin and Etoposide in Participants With ES-SCLC

Who this might be right for
Small-cell Lung Cancer
Chinese Academy of Medical Sciences 69
Testing effectiveness (Phase 2)Study completedNCT00030433
What this trial is testing

S0119: Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Lung Cancer
SWOG Cancer Research Network 85
Testing effectiveness (Phase 2)Study completedNCT04702880
What this trial is testing

BMS-986012 in Combination With Carboplatin, Etoposide, and Nivolumab as First-line Therapy in Extensive-stage Small Cell Lung Cancer

Who this might be right for
Extensive-stage Small Cell Lung Cancer
Bristol-Myers Squibb 135
Early research (Phase 1)WithdrawnNCT03166254
What this trial is testing

Personalized Therapeutic Anti-tumor Vaccine With Pembrolizumab and Standard of Care Chemotherapy in Squamous Non-Small Cell Lung Cancer and Extensive Stage Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung CancerNSCLCNon-small Cell Lung Cancer+1 more
Washington University School of Medicine
Large-scale testing (Phase 3)UnknownNCT00519805
What this trial is testing

Dalteparin in Preventing Blood Clots in Patients With Lung Cancer

Who this might be right for
Lung CancerThromboembolism
Velindre NHS Trust 2,200
Early research (Phase 1)Not Yet RecruitingNCT07550842
What this trial is testing

A Clinical Study for the Safety and Efficacy of BL0020 Injection in Combination With Toripalimab Injection in Patients With Recurrent Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Carcinoma of Lung
Shanghai Best-Link Bioscience, LLC 33
Large-scale testing (Phase 3)Study completedNCT00290953
What this trial is testing

Evaluation of the Overall Survival of Meclinertant Versus Placebo After a First Line Chemotherapy With Cisplatin + Etoposide

Who this might be right for
Lung CancerPulmonary NeoplasmsSmall Cell Lung Cancer
Sanofi 432
Testing effectiveness (Phase 2)Looking for participantsNCT07141264
What this trial is testing

Adebrelimab Combine With Etoposide Capsules in ES-SCLC Maintenance Therapy

Who this might be right for
SCLC,Extensive Stage
Tang-Du Hospital 32
Testing effectiveness (Phase 2)Looking for participantsNCT07110103
What this trial is testing

Golidocitinib With PD-1 Inhibitors as Maintenance Treatment for Previously Untreated ES-SCLC

Who this might be right for
SCLCSCLC, Extensive Stage
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 20
Not applicableStudy completedNCT04920981
What this trial is testing

Atezolizumab Combined With Chemotherapy in Extensive Stage SCLC

Who this might be right for
Small Cell Lung Cancer
Intergroupe Francophone de Cancerologie Thoracique 518
Not applicableNot Yet RecruitingNCT07400575
What this trial is testing

Anlotinib in Cross-line Treatment of NSCLC and SCLC

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)SCLC, Extensive Stage
Henan Cancer Hospital 350
Early research (Phase 1)Study completedNCT00003022
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal Cancer

Who this might be right for
Brain and Central Nervous System TumorsIntraocular MelanomaLung Cancer+4 more
Memorial Sloan Kettering Cancer Center
Post-approval studies (Phase 4)Study completedNCT05071703
What this trial is testing

Evaluation of TRILACICLIB in Chinese Patients With Extensive-stage Small Cell Lung Cancer (ES-SCLC) for Chemotherapy-induced Myelosuppression, Antitumor Effects of Combination Regimens, and Safety in a Real-world Study

Who this might be right for
Extensive-stage Small-cell Lung Cancer
Jiangsu Simcere Pharmaceutical Co., Ltd. 30
Testing effectiveness (Phase 2)Study completedNCT04660097
What this trial is testing

Anlotinib Plus Durvalumab-Platinum-Etoposide in First-line Treatment Extensive Small-cell Lung Cancer

Who this might be right for
SCLC, Extensive Stage
Henan Cancer Hospital 34
Not applicableNot Yet RecruitingNCT06825208
What this trial is testing

Etoposide Plus Benmelstobart Followed by Maintenance Therapy of Benmelstobart Plus Anlotinib in First-line Treatment of Elderly Patients with Extensive Stage Small Cell Lung Cancer: a Single-arm, Prospective Trial

Who this might be right for
Small Cell Lung Cancer Extensive StageELDERLY PEOPLE
Nanjing First Hospital, Nanjing Medical University 29
Testing effectiveness (Phase 2)Study completedNCT00294190
What this trial is testing

Higher Dose Weekly Topotecan In The Treatment Of Patients With Extensive Stage Small-Cell Lung Cancer

Who this might be right for
Small Cell Lung CancerCarcinoma, Small Cell
SCRI Development Innovations, LLC 38
Testing effectiveness (Phase 2)Study completedNCT04462276
What this trial is testing

Thoracic RadiothErapy With Atezolizumab in Small Cell lUng canceR Extensive Disease

Who this might be right for
Small Cell Lung Cancer Extensive StageThoracic Radiotherapy
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 68
Not applicableAvailableNCT07535359
What this trial is testing

Medical Access Program for Ifinatamab Deruxtecan in 3L+ Pretreated Extensive-stage Small Cell Lung Cancer

Who this might be right for
SCLCExtensive-stage Small Cell Lung Cancer
Daiichi Sankyo
Next Page